Lab-grown immune cells take on seven viruses in transplant patients
NCT ID NCT03180216
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This early-stage study tests whether immune cells grown from a donor's blood can safely fight or prevent seven different viruses in people who have had a bone marrow transplant. About 32 participants will receive these cells either as a preventive measure or as a treatment for active infections that did not get better with standard care. The main goal is to check for side effects, such as graft-versus-host disease or other serious reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE MARROW TRANSPLANT INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Childrens National Medical Center
Washington D.C., District of Columbia, 20010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists launch major study to unlock secrets of respiratory infections
- Could stopping antibiotics early help elderly virus patients?
- 1,000+ kids tracked from birth to unlock secrets of childhood lung infections
- 730 transplant Patients' records reveal hidden viral risks
- New AI-Guided blood test could slash unnecessary antibiotic use